Peace Harbor Hospice 2230 Kingwood Street, Florence, OR, 97439 | |
(541) 997-3418 |
News Archive
The beneficial effects of nanotechnology innovation on human health and the environment are the focus of a comprehensive report to be presented at the Nano Science and Technology Institute's Nanotech Conference and Expo 2010 in Anaheim, CA, June 21-24, 2010. The report, titled "Nanotechnology, Health and the Environment," was authored by shareholders of the international law firm Greenberg Traurig, LLP; the managing director of Intertox, Inc.,
K-V Pharmaceutical Company announced today that it has received notice from the U.S. Food and Drug Administration ("FDA") of the successful completion of an inspection of the Company's facilities and approval to return its first product to market. Under the Company's Consent Decree, successful FDA inspections of the Company's quality systems, processes and facilities are expected to be required before K-V is permitted to resume manufacturing and shipment of particular products.
Joshua and Jacob Spates, all of seven months old spent their initial months outside the womb as conjoined twins. Now they are recovering in the pediatric intensive care unit of a Memphis hospital after a successful 13-hour surgery to separate them.
Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.
› Verified 2 days ago
Name | Peace Harbor Hospice |
---|---|
Location | 2230 Kingwood Street, Florence, Oregon |
Hospice ID | 381536 |
Category | Part of a hospital |
Ownership Type | Voluntary Non-profit - Other |
Profit Type | NON-PROFIT |
SSA county code | 190 |
News Archive
The beneficial effects of nanotechnology innovation on human health and the environment are the focus of a comprehensive report to be presented at the Nano Science and Technology Institute's Nanotech Conference and Expo 2010 in Anaheim, CA, June 21-24, 2010. The report, titled "Nanotechnology, Health and the Environment," was authored by shareholders of the international law firm Greenberg Traurig, LLP; the managing director of Intertox, Inc.,
K-V Pharmaceutical Company announced today that it has received notice from the U.S. Food and Drug Administration ("FDA") of the successful completion of an inspection of the Company's facilities and approval to return its first product to market. Under the Company's Consent Decree, successful FDA inspections of the Company's quality systems, processes and facilities are expected to be required before K-V is permitted to resume manufacturing and shipment of particular products.
Joshua and Jacob Spates, all of seven months old spent their initial months outside the womb as conjoined twins. Now they are recovering in the pediatric intensive care unit of a Memphis hospital after a successful 13-hour surgery to separate them.
Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.
› Verified 2 days ago
NPI Number | 1215918719 |
Organization Name | Peacehealth |
Address | 2230 Kingwood Street Florence, Oregon, 97439 |
Phone Number | (541)997-3418 |
News Archive
The beneficial effects of nanotechnology innovation on human health and the environment are the focus of a comprehensive report to be presented at the Nano Science and Technology Institute's Nanotech Conference and Expo 2010 in Anaheim, CA, June 21-24, 2010. The report, titled "Nanotechnology, Health and the Environment," was authored by shareholders of the international law firm Greenberg Traurig, LLP; the managing director of Intertox, Inc.,
K-V Pharmaceutical Company announced today that it has received notice from the U.S. Food and Drug Administration ("FDA") of the successful completion of an inspection of the Company's facilities and approval to return its first product to market. Under the Company's Consent Decree, successful FDA inspections of the Company's quality systems, processes and facilities are expected to be required before K-V is permitted to resume manufacturing and shipment of particular products.
Joshua and Jacob Spates, all of seven months old spent their initial months outside the womb as conjoined twins. Now they are recovering in the pediatric intensive care unit of a Memphis hospital after a successful 13-hour surgery to separate them.
Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.
› Verified 2 days ago
Quality Measure | Provider Score | National Score |
---|---|---|
Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 95.1 | 93.6 |
Patients who were checked for pain at the beginning of hospice care | 99.2 | 93.9 |
Patients who got a timely and thorough pain assessment when pain was identified as a problem | 92.3 | 77.7 |
Patients who were checked for shortness of breath at the beginning of hospice care | 99.2 | 97.3 |
Patients who got timely treatment for shortness of breath | 97.4 | 94.6 |
Patients taking opioid pain medication who were offered care for constipation | 94.6 | 93.3 |
News Archive
The beneficial effects of nanotechnology innovation on human health and the environment are the focus of a comprehensive report to be presented at the Nano Science and Technology Institute's Nanotech Conference and Expo 2010 in Anaheim, CA, June 21-24, 2010. The report, titled "Nanotechnology, Health and the Environment," was authored by shareholders of the international law firm Greenberg Traurig, LLP; the managing director of Intertox, Inc.,
K-V Pharmaceutical Company announced today that it has received notice from the U.S. Food and Drug Administration ("FDA") of the successful completion of an inspection of the Company's facilities and approval to return its first product to market. Under the Company's Consent Decree, successful FDA inspections of the Company's quality systems, processes and facilities are expected to be required before K-V is permitted to resume manufacturing and shipment of particular products.
Joshua and Jacob Spates, all of seven months old spent their initial months outside the womb as conjoined twins. Now they are recovering in the pediatric intensive care unit of a Memphis hospital after a successful 13-hour surgery to separate them.
Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.
› Verified 2 days ago
Home Health Aides | 2 |
Counselors | 2 |
Medical Social Workers | 3 |
Physicians | 1 |
Registered Nurses | 13 |
Total Employees | 21 |
---|
News Archive
The beneficial effects of nanotechnology innovation on human health and the environment are the focus of a comprehensive report to be presented at the Nano Science and Technology Institute's Nanotech Conference and Expo 2010 in Anaheim, CA, June 21-24, 2010. The report, titled "Nanotechnology, Health and the Environment," was authored by shareholders of the international law firm Greenberg Traurig, LLP; the managing director of Intertox, Inc.,
K-V Pharmaceutical Company announced today that it has received notice from the U.S. Food and Drug Administration ("FDA") of the successful completion of an inspection of the Company's facilities and approval to return its first product to market. Under the Company's Consent Decree, successful FDA inspections of the Company's quality systems, processes and facilities are expected to be required before K-V is permitted to resume manufacturing and shipment of particular products.
Joshua and Jacob Spates, all of seven months old spent their initial months outside the womb as conjoined twins. Now they are recovering in the pediatric intensive care unit of a Memphis hospital after a successful 13-hour surgery to separate them.
Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.
› Verified 2 days ago
Others | 49 |
Total Volunteers | 49 |
---|
News Archive
The beneficial effects of nanotechnology innovation on human health and the environment are the focus of a comprehensive report to be presented at the Nano Science and Technology Institute's Nanotech Conference and Expo 2010 in Anaheim, CA, June 21-24, 2010. The report, titled "Nanotechnology, Health and the Environment," was authored by shareholders of the international law firm Greenberg Traurig, LLP; the managing director of Intertox, Inc.,
K-V Pharmaceutical Company announced today that it has received notice from the U.S. Food and Drug Administration ("FDA") of the successful completion of an inspection of the Company's facilities and approval to return its first product to market. Under the Company's Consent Decree, successful FDA inspections of the Company's quality systems, processes and facilities are expected to be required before K-V is permitted to resume manufacturing and shipment of particular products.
Joshua and Jacob Spates, all of seven months old spent their initial months outside the womb as conjoined twins. Now they are recovering in the pediatric intensive care unit of a Memphis hospital after a successful 13-hour surgery to separate them.
Today, the U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult patients with advanced prostate cancer.
› Verified 2 days ago
Peace Harbor Hospice Location: 2230 Kingwood Street, Florence, Oregon, 97439 Phone: (541) 997-3418 |